Aspo posted Q1 2026 net sales of €114.1 million, down 1.7% YoY, due to weakness in its ESL Shipping unit.
Comparable EBITA fell slightly, while earnings per share were €0.50 and net income reached €16.1 million.
Free cash flow rose to €50 million, ROE hit 37%, and the divestment of Leipurin bolstered the balance sheet.
Aspo forecasts 2026 comparable EBITA to rise from €29.4 million in 2025, expecting shipping demand recovery but Q2 docking pressure.